|
|
- Combination of a Glucagon-Like Peptide 1 Analog and a Sodium-Glucose Cotransporter 2 Inhibitor Improves Lipid Metabolism Compared to the Monotherapies in Experimental Metabolic Syndrome
Here we evaluated the association of the glucagon-like peptide 1 (GLP-1) analog, liraglutide, and the sodium-glucose cotransporter-2 (SGLT-2) inhibitor, canagliflozin, on the improvement of metabolic syndrome symptoms in a high-fat diet (HFD)-induced obesity rat model.
Read More >> - Bone Mineral Density as a Predictor of Cardiovascular Disease in Women: A Real-World Retrospective Study
Atherosclerotic cardiovascular disease (ASCVD) in women remains understudied, under-diagnosed, and under-treated. Traditional risk factors affect men’s and women’s hearts differently. However, the current risk stratification tools do not consider such sex-specific factors.
Read More >> - Thyroid-Stimulating Hormone and Estimated Glomerular Filtration Rate
The retrospective study investigated thyroid function and CKD, and assessed the relationship between thyroid-stimulating hormone (TSH) and urine albumin/creatinine ratio (ACR), and the slope of estimated glomerular filtration rate (eGFR), stratified by CKD grades.
Read More >> - Sedentary Lifestyle Attenuates Positive Metabolic Effect of Regular Physical Exercise
The aim of the study was to evaluate the influence of the duration of sedentary time on blood lipids and anthropometric parameters in people practicing resistance training in leisure time. Our study included 213 subjects without any history of cardiovascular disease. The target group (169 subjects) had at least two 90-min sessions of resistance training per week for at least 12 months prior to study commencing.
Read More >> - Extreme Elevation of Alkaline Phosphatase in a Pregnancy Complicated by Uncontrolled Chronic Hypertension and Its Association With Placental Pathology
Alkaline phosphatase (ALP) is an enzyme produced primarily by cells of liver, bone, kidney, small intestine and placenta, each detectable by a specific isoenzyme. It appears in maternal serum in the second trimester and increases progressively with gestational age.
Read More >>
Viewpoints |
|
| Featured |
|
| Maternal and Childhood Diet and Human Type 1 Diabetes Risk | |||
Key Clinical Image |
|
![]() Mediastinal Mass as First Clinical Manifestation of Medullary Thyroid Microcarcinoma in a Patient With Hashimoto’s Thyroiditis |
|
|
Vol. 12, No. 6, Dec 2022
Table of Contents
Review
Protective Effect of Metformin on Venous Thrombosis in Diabetic Patients: Findings From a Systematic Review | Abstract HTML PDF |
Sultan Alqahtani![]() ![]() |
161-167 |
doi: https://doi.org/10.14740/jem848 |
Original Article
Combination of a Glucagon-Like Peptide 1 Analog and a Sodium-Glucose Cotransporter 2 Inhibitor Improves Lipid Metabolism Compared to the Monotherapies in Experimental Metabolic Syndrome | Abstract HTML PDF |
Isaias dos Santos Silva![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
168-177 |
doi: https://doi.org/10.14740/jem843 |
Maternal and Childhood Diet and Human Type 1 Diabetes Risk | Abstract HTML PDF Suppl1 |
Alexia G. Abela, Stephen Fava![]() |
178-187 |
doi: https://doi.org/10.14740/jem846 |
Short Communication
Identification of Two Rare Homozygote Missense Variants in the IRS1 Gene in a Patient With Early Gestational Diabetes: A Case Study | Abstract HTML PDF Suppl1 Suppl2 Suppl3 |
Maab Babiker Mansour, Uzma Inayat, Aml Mohamed Nada, Hassen Hadj Kacem![]() |
188-197 |
doi: https://doi.org/10.14740/jem842 |
Case Report
Mediastinal Mass as First Clinical Manifestation of Medullary Thyroid Microcarcinoma in a Patient With Hashimoto’s Thyroiditis | Abstract HTML PDF |
Victor Raul Garcia-Ruiz![]() ![]() ![]() ![]() ![]() |
198-201 |
doi: https://doi.org/10.14740/jem841 |
Conversion From Hypothyroidism to Hyperthyroidism and Back After Anti-SARS-CoV-2 Vaccination | Abstract HTML PDF |
Andrey Valerievich Ushakov![]() |
202-208 |
doi: https://doi.org/10.14740/jem833 |